ASX - By Stock
|
ATH |
Re:
New eye / PD related study by Finkelstein
|
|
Scottsmyname
|
3 |
389 |
1 |
05:38 |
05:38 |
ASX - By Stock
|
3
|
389
|
1
|
|
ASX - By Stock
|
ATH |
Re:
New eye / PD related study by Finkelstein
|
|
Scottsmyname
|
3 |
389 |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
3
|
389
|
1
|
|
ASX - By Stock
|
RR1 |
Re:
Ann: Response to ASX Price and Volume Query
|
|
Scottsmyname
|
18 |
4.8K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
18
|
4.8K
|
0
|
|
ASX - By Stock
|
RR1 |
Re:
Ann: Response to ASX Price and Volume Query
|
|
Scottsmyname
|
18 |
4.8K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
18
|
4.8K
|
4
|
|
ASX - By Stock
|
RR1 |
Re:
Ann: Response to ASX Price and Volume Query
|
|
Scottsmyname
|
18 |
4.8K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
18
|
4.8K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Ceasing to be a substantial holder
|
|
Scottsmyname
|
8 |
1.3K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
1.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned
|
|
Scottsmyname
|
4 |
806 |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
4
|
806
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Ceasing to be a substantial holder
|
|
Scottsmyname
|
8 |
1.3K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
1.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Ceasing to be a substantial holder
|
|
Scottsmyname
|
8 |
1.3K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
1.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned
|
|
Scottsmyname
|
4 |
806 |
5 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
4
|
806
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Biomarkers for AD predementia by Masters et al
|
|
Scottsmyname
|
5 |
925 |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
5
|
925
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Hereditary hemochromatosis as potential target for ATH434 treatment
|
|
Scottsmyname
|
1 |
495 |
4 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
1
|
495
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
2 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
14
|
3.2K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
Scottsmyname
|
14 |
3.2K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
14
|
3.2K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
18
|
4.5K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16
|
3.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16
|
3.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16
|
3.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16
|
3.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16
|
3.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
18
|
4.5K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
18
|
4.5K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
18
|
4.5K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
10 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
18
|
4.5K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
16
|
3.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Scottsmyname
|
16 |
3.1K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
16
|
3.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
4.5K
|
2
|
|
ASX - By Stock
|
14D |
Re:
Ann: Aurora Energy Precinct Transmission Access Update
|
|
Scottsmyname
|
11 |
4.8K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
11
|
4.8K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
4.5K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
4.5K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
Scottsmyname
|
10 |
3.1K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
10
|
3.1K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Orphan drug week - 22nd to 26th April
|
|
Scottsmyname
|
24 |
6.2K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
6.2K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
4.5K
|
2
|
|
ASX - By Stock
|
RR1 |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Scottsmyname
|
9 |
2.8K |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
9
|
2.8K
|
5
|
|
ASX - By Stock
|
RR1 |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Scottsmyname
|
9 |
2.8K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
9
|
2.8K
|
0
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Drilling of 4 Compelling Targets Completed - Central Yilgarn
|
|
Scottsmyname
|
21 |
7.5K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
21
|
7.5K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
9 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
18
|
4.5K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Scottsmyname
|
18 |
4.5K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
18
|
4.5K
|
4
|
|
ASX - By Stock
|
SRN |
Re:
SRN Chart
|
|
Scottsmyname
|
515 |
159K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
515
|
159K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Scottsmyname
|
23K |
11M |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
23K
|
11M
|
7
|
|
ASX - By Stock
|
SRN |
Re:
SRN Chart
|
|
Scottsmyname
|
515 |
159K |
0 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
515
|
159K
|
0
|
|
ASX - By Stock
|
SRN |
Re:
SRN Chart
|
|
Scottsmyname
|
515 |
159K |
0 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
515
|
159K
|
0
|
|